Cargando…
Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study
The United States Food and Drug Administration has approved budesonide in infantile asthma but nebulization of infants under budesonide has the risk of relapse of asthma. The objective of the present study was to compare the effectiveness and safety of fluticasone step-down treatment with budesonide...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027130/ https://www.ncbi.nlm.nih.gov/pubmed/32104218 http://dx.doi.org/10.3892/etm.2019.8401 |